EVERMIND Holdings, Inc. Unveils Strategic Pivot to Human Optimization and Longevity Sectors

BitFrontier Capital Holdings, Inc. (OTC: BFCH), now transitioning to EVERMIND Holdings, Inc., has announced a significant strategic pivot towards the burgeoning sectors of human optimization, cognitive performance, and longevity infrastructure. This move, spearheaded by new CEO and controlling shareholder Dr. Jordan P. Balencic, aims to reposition the company as a leader in wellness and performance enhancement through a multi-division platform.

The company's ambitious business plan includes early restructuring achievements such as retiring over $2 million in legacy convertible debt and reducing total liabilities to under $94,000. These steps are part of a broader strategy to solidify the company's financial standing and restore investor confidence. A notable aspect of the plan is the introduction of a fixed-price equity conversion at $0.01 per share, designed to mitigate variable-rate dilution from past obligations and lay a transparent groundwork for future expansion.

EVERMIND Holdings is structured around three key divisions: EVERMIND Labs, EVERMIND Technologies, and EVERMIND Manufacturing. Each division is tailored to tap into scalable opportunities within consumer wellness brands, the intersection of brain performance and digital health technologies, and domestic co-manufacturing infrastructure, respectively. This diversified strategy aims to not only drive revenue but also spur innovation and enhance supply chain resilience.

To fuel its strategic objectives, EVERMIND Holdings is initiating a $150,000 seed round aimed at covering rebranding efforts, regulatory filings, and the development of corporate communications strategies. The company is also considering a potential Regulation A offering in 2025, depending on share price performance and regulatory approvals. While no definitive acquisition agreements are in place, preliminary discussions are underway regarding potential transactions.

For more detailed insights into EVERMIND Holdings' strategic direction and business plan, stakeholders are encouraged to visit the company's official website at https://evermindholdings.com. This platform, alongside the OTC Markets Disclosure Portal and public press releases, serves as a key channel for corporate communications. This strategic overhaul under Dr. Balencic's leadership signifies a pivotal step towards establishing EVERMIND Holdings as a frontrunner in the human optimization and longevity industries.